Peter Bartz‐Bazzanella

647 total citations
23 papers, 388 citations indexed

About

Peter Bartz‐Bazzanella is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Peter Bartz‐Bazzanella has authored 23 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 8 papers in Hematology and 7 papers in Immunology. Recurrent topics in Peter Bartz‐Bazzanella's work include Rheumatoid Arthritis Research and Therapies (12 papers), Autoimmune and Inflammatory Disorders Research (8 papers) and Spondyloarthritis Studies and Treatments (5 papers). Peter Bartz‐Bazzanella is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Autoimmune and Inflammatory Disorders Research (8 papers) and Spondyloarthritis Studies and Treatments (5 papers). Peter Bartz‐Bazzanella collaborates with scholars based in Germany, Estonia and United States. Peter Bartz‐Bazzanella's co-authors include M. C. Jendro, Cornelia M. Weyand, Jörg J. Goronzy, Debby Walser-Kuntz, William T. Hu, E. Genth, Elisabeth Keller, Rudolf Mierau, Thomas Dick and E. D. Albert and has published in prestigious journals such as Journal of Clinical Investigation, The American Journal of Cardiology and Frontiers in Immunology.

In The Last Decade

Peter Bartz‐Bazzanella

21 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Bartz‐Bazzanella Germany	9	183	175	95	71	60	23	388
H-P Tony Germany	9	242 1.3×	174 1.0×	46 0.5×	39 0.5×	69 1.1×	23	381
Roman Yatsyshyn Ukraine	9	200 1.1×	413 2.4×	68 0.7×	89 1.3×	35 0.6×	36	544
Maame-Boatemaa Amissah-Arthur Ghana	6	219 1.2×	117 0.7×	63 0.7×	26 0.4×	30 0.5×	14	323
A. Gibofsky United States	2	206 1.1×	93 0.5×	27 0.3×	51 0.7×	81 1.4×	3	320
Gerd R. Burmester Germany	3	172 0.9×	148 0.8×	55 0.6×	22 0.3×	52 0.9×	4	301
Michelene Hearth-Holmes United States	11	181 1.0×	109 0.6×	45 0.5×	50 0.7×	22 0.4×	18	361
Gerardo Quintana Colombia	11	212 1.2×	85 0.5×	40 0.4×	38 0.5×	53 0.9×	35	352
S. Shevchuk Ukraine	6	212 1.2×	475 2.7×	82 0.9×	139 2.0×	30 0.5×	37	581
Helen Pahau Australia	9	156 0.9×	288 1.6×	102 1.1×	30 0.4×	26 0.4×	11	538
Georgina Salvador Spain	13	348 1.9×	109 0.6×	39 0.4×	49 0.7×	140 2.3×	20	501

Countries citing papers authored by Peter Bartz‐Bazzanella

Since Specialization

Citations

This map shows the geographic impact of Peter Bartz‐Bazzanella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bartz‐Bazzanella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bartz‐Bazzanella more than expected).

Fields of papers citing papers by Peter Bartz‐Bazzanella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bartz‐Bazzanella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bartz‐Bazzanella. The network helps show where Peter Bartz‐Bazzanella may publish in the future.

Co-authorship network of co-authors of Peter Bartz‐Bazzanella

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bartz‐Bazzanella. A scholar is included among the top collaborators of Peter Bartz‐Bazzanella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bartz‐Bazzanella. Peter Bartz‐Bazzanella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kleinert, Stefan, Kirsten Karberg, Peer Aries, et al.. (2025). Potential of digital applications for self-management and other outcomes in inflammatory rheumatic diseases: a systematic literature review. Frontiers in Medicine. 12. 1617151–1617151.

Witte, Torsten, Matthias Englbrecht, Marc Schmalzing, et al.. (2025). Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis – a retrospective analysis from the RHADAR database. Rheumatology International. 45(5). 100–100.

Englbrecht, Matthias, Marc Schmalzing, Peter Bartz‐Bazzanella, et al.. (2024). Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study. Frontiers in Immunology. 15. 1445680–1445680. 1 indexed citations

Englbrecht, Matthias, Torsten Witte, Marc Schmalzing, et al.. (2024). Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database. Frontiers in Immunology. 15. 1395968–1395968. 5 indexed citations

Englbrecht, Matthias, Torsten Witte, Marc Schmalzing, et al.. (2024). Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network. Rheumatology International. 44(10). 2057–2066. 2 indexed citations

Kleinert, Stefan, Florian Schuch, Monika Ronneberger, et al.. (2023). Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices. Rheumatology International. 44(4). 653–661. 2 indexed citations

Morf, Harriet, Yuriy Ignatyev, Elizabeth Araújo, et al.. (2022). Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based study. Rheumatology International. 43(3). 495–502. 17 indexed citations

Knitza, Johannes, Felix Kluge, Stefan Kleinert, et al.. (2022). Machine learning-based improvement of an online rheumatology referral and triage system. Frontiers in Medicine. 9. 954056–954056. 14 indexed citations

Kleinert, Stefan, Florian Schuch, Monika Ronneberger, et al.. (2022). Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis. Rheumatology International. 43(1). 89–97. 5 indexed citations

10.

Knitza, Johannes, Felix Muehlensiepen, Yuriy Ignatyev, et al.. (2022). Patient's Perception of Digital Symptom Assessment Technologies in Rheumatology: Results From a Multicentre Study. Frontiers in Public Health. 10. 844669–844669. 29 indexed citations

11.

Englbrecht, Matthias, Peter Bartz‐Bazzanella, Peer Aries, et al.. (2021). Prevalence of Depressive Symptoms in Patients With Psoriatic Arthritis: Have Numbers Changed During the COVID-19 Pandemic?. Frontiers in Medicine. 8. 748262–748262. 4 indexed citations

12.

Knitza, Johannes, Christina Bergmann, Eleni Kampylafka, et al.. (2020). AB1346-HPR REAL-WORLD EFFECTIVENESS AND PERCEIVED USEFULNESS OF SYMPTOM CHECKERS IN RHEUMATOLOGY: INTERIM REPORT FROM THE PROSPECTIVE MULTICENTER BETTER STUDY. Annals of the Rheumatic Diseases. 79. 1961–1961. 1 indexed citations

13.

Wendler, J., Gerd R Burmester, H. Sörensen, et al.. (2014). Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients. Arthritis Research & Therapy. 16(2). R80–R80. 44 indexed citations

14.

Iking‐Konert, Christof, et al.. (2013). Interleukin-6-Blockade als potenzielles therapeutisches Target bei entzündlich-rheumatischen Erkrankungen. Zeitschrift für Rheumatologie. 73(3). 269–276. 8 indexed citations

15.

Mierau, Rudolf, et al.. (1999). An update on HLA association of Mi-2 autoantibodies: The association with a tryptophan at position 9 of the HLA-DR? chain is strong but not absolute. Arthritis & Rheumatism. 42(7). 1552–1553. 4 indexed citations

16.

Bartz‐Bazzanella, Peter, et al.. (1997). Diffuse Fasziitis nach einer Borrelien-Infektion ein kasuistischer Beitrag (Diffuse fasciitis associated with Borrelia burgdorferi infection a case report). Zeitschrift für Rheumatologie. 56(4). 214–221. 3 indexed citations

17.

Mierau, Rudolf, Thomas Dick, Peter Bartz‐Bazzanella, et al.. (1996). Strong association of dermatomyositis‐specific Mi‐2 autoantibodies with a tryptophan at position 9 of the HLA‐DRβ chain. Arthritis & Rheumatism. 39(5). 868–876. 52 indexed citations

18.

Goronzy, Jörg J., Peter Bartz‐Bazzanella, William T. Hu, et al.. (1994). Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.. Journal of Clinical Investigation. 94(5). 2068–2076. 130 indexed citations

19.

Bartz‐Bazzanella, Peter, et al.. (1992). [Eosinophilia-myalgia syndrome with fasciitis and interstitial myositis after L-tryptophan administration].. PubMed. 51(1). 3–13. 2 indexed citations

20.

Bartz‐Bazzanella, Peter, et al.. (1991). Determination of left atrial area and volume by cross-sectional echocardiography in healthy infants and children. The American Journal of Cardiology. 68(10). 1073–1078. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact